DSG2 and pancreatic neoplasm: Clinically, high expression of DSG2 correlates with significantly reduced survival rates in patients (data available from Human Protein Atlas, version 23.0, https://www.proteinatlas.org/ENSG00000046604-DSG2/pathology/pancreatic+cancer), suggesting a relevant contribution of this adhesion protein to the pathological cascade of pancreatic cancer.